TAZOPER

This brand name is authorized in Turkey.

Active ingredients

The drug TAZOPER contains a combination of these active pharmaceutical ingredients (APIs):

1	Piperacillin UNII M98T69Q7HP - PIPERACILLIN SODIUM
	Piperacillin is a broad-spectrum, semisynthetic penicillin. Piperacillin exerts bactericidal activity by inhibition of both septum and cell-wall synthesis.
	Read more about Piperacillin
2	Tazobactam UNII UXA545ABTT - TAZOBACTAM SODIUM
	Tazobactam is a beta-lactam structurally related to penicillins. It is an inhibitor of many molecular Class A beta-lactamases, including CTX-M, SHV, and TEM enzymes.
	Read more about Tazobactam

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01CR05	Piperacillin and enzyme inhibitor	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CR Combinations of penicillins, incl. beta-lactamase inhibitors
Discover more medicines within J01CR05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
TR	İlaç ve Tıbbi Cihaz Kurumu	8699541794206, 8699541794305